S204-0122 Screening compound: 1-(4-{1-methyl-1H,4H,6H,7H-pyrano[4,3-c]pyrazol-3-yl}piperidin-1-yl)-2-(3-methylphenyl)ethan-1-one

S204-0122 Screening compound: 1-(4-{1-methyl-1H,4H,6H,7H-pyrano[4,3-c]pyrazol-3-yl}piperidin-1-yl)-2-(3-methylphenyl)ethan-1-one
S204-0122 Screening compound: 1-(4-{1-methyl-1H,4H,6H,7H-pyrano[4,3-c]pyrazol-3-yl}piperidin-1-yl)-2-(3-methylphenyl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S204-0122
1-(4-{1-methyl-1H,4H,6H,7H-pyrano[4,3-c]pyrazol-3-yl}piperidin-1-yl)-2-(3-methylphenyl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S204-0122

Molecular Formula

C21H27N3O2 (C21 H27 N3 O2)

Compound Name

1-(4-{1-methyl-1H,4H,6H,7H-pyrano[4,3-c]pyrazol-3-yl}piperidin-1-yl)-2-(3-methylphenyl)ethan-1-one

IUPAC name

1-(4-{1-methyl-1H4H6H7H-pyrano[43-c]pyrazol-3-yl}piperidin-1-yl)-2-(3-methylphenyl)ethan-1-one

SMILES

Cc1cccc(CC(N(CC2)CCC2c2nn(C)c3c2COCC3)=O)c1

InChI

InChI=1S/C21H27N3O2/c1-15-4-3-5-16(12-15)13-20(25)24-9-6-17(7-10-24)21-18-14-26-11-8-19(18)23(2)22-21/h3-5,12,17H,6-11,13-14H2,1-2H3

InChI Key

FAIUNOAKPDSKSP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29008030

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

353.46

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

2.770

Distribution Coefficient, logD

2.770

Water Solubility, LogSw

-2.75

Polar Surface Area

39.433

Acid Dissociation Constant (pKa)

18.21

Base Dissociation Constant (pKb)

1.90

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.40

S204-0122 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with S204-0122 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S204-0122?
Check Price and Availability of S204-0122, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S204-0122 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S204-0122
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S204-0122
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S204-0122 available by request